← Leaderboards
Randi Hornback
Battelle Centers/Pub Hlth Res & Evaluatn
$23,448,686
Attributed
$23,448,686
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $10.3M · FY2016–21$20M$15M$10M$5M$0
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$23,448,686 · 1
By mechanism
N01$23,448,686 · 1
Top collaborators
No co-investigators on record.
Most similar at Battelle Centers/Pub Hlth Res & Evaluatn
Same institution · by research overlap
- Mary Bruce$27,703,129
- Thomas Rudge$58,444,221
- Carol Sabourin$8,207,528
- Tom Rudge$29,820
Others in their field
Top investigators on “Novel Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$450,123,047
- Barton F Haynes · Duke University$322,890,080
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$312,341,639
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- Dennis R. Burton · Scripps Research Institute$274,644,614
- Sharon A Nachman · Johns Hopkins University$209,857,565
Research focus
Novel VaccinesEfficacy TestingProduct DevelopmentServicesVaccinesContractsToxicity TestsFeasibility StudiesCommunicable DiseasesImmunogenicityAssay DevelopmentSafety TestingEvaluation/TestingSamplingEmerging Communicable DiseasesBioterrorismTesting ServicesDrug ResistancePathogenBiologicalVaccine DevelopmentZika Virus VaccineEbola VaccinesFilovirus
Grant awards (36)
Task X21: Preparedness for Testing NIAID Priority Vaccines in General Safety and Toxicology Studies$426,458
N01 · FY2021 · AI · contact PI
Task X15: Evaluation of Ebolavirus and Other Filovirus Vaccines in a Novel Animal Model$68,844
N01 · FY2021 · AI · contact PI
Task X21: Preparedness for Testing NIAID Priority Vaccines in General Safety and Toxicology Studies$814,926
N01 · FY2020 · AI · contact PI
TASK X26: Immunogenicity and Efficacy Testing of Zika Vaccine Candidates in Animal Models$101,932
N01 · FY2020 · AI · contact PI
Task X20: Clinical Sample Testing for Zika Virus Vaccines$60,752
N01 · FY2020 · AI · contact PI
Task X19: Development of Assays and Reagents for Zika Virus Vaccines$55,426
N01 · FY2020 · AI · contact PI
Task X17: Malaria Vaccine Safety and Toxicology Studies$37,734
N01 · FY2020 · AI · contact PI
TASK X23: Control Animal Meta-Analysis for Ebola and Other Filoviruses$24,251
N01 · FY2020 · AI · contact PI
TASK X26: Immunogenicity and Efficacy Testing of Zika Vaccine Candidates in Animal Models$1,481,147
N01 · FY2019 · AI · contact PI
Task X19: Development of Assays and Reagents for Zika Virus Vaccines$1,105,345
N01 · FY2019 · AI · contact PI
TASK X25: Preparedness for Testing NIAID Priority Vaccines in Neurovirulence and Reproductive Toxicology Studies$784,072
N01 · FY2019 · AI · contact PI
Task X15: Evaluation of Ebolavirus and Other Filovirus Vaccines in a Novel Animal Model$597,706
N01 · FY2019 · AI · contact PI
TASK X23: Control Animal Meta-Analysis for Ebola and Other Filoviruses$279,987
N01 · FY2019 · AI · contact PI
Task X20: Clinical Sample Testing for Zika Virus Vaccines$39,089
N01 · FY2019 · AI · contact PI
Task X15: Evaluation of Ebolavirus and Other Filovirus Vaccines in a Novel Animal Model$1,483,578
N01 · FY2018 · AI · contact PI
Task X19: Development of Assays and Reagents for Zika Virus Vaccines$1,349,169
N01 · FY2018 · AI · contact PI
TASK X26: Immunogenicity and Efficacy Testing of Zika Vaccine Candidates in Animal Models$942,954
N01 · FY2018 · AI · contact PI
TASK X23: Control Animal Meta-Analysis for Ebola and Other Filoviruses$81,323
N01 · FY2018 · AI · contact PI
Task X20: Clinical Sample Testing for Zika Virus Vaccines$21,888
N01 · FY2018 · AI · contact PI
Task X17: Malaria Vaccine Safety and Toxicology Studies$790,279
N01 · FY2017 · AI · contact PI
TASK X26: Immunogenicity and Efficacy Testing of Zika Vaccine Candidates in Animal Models$675,049
N01 · FY2017 · AI · contact PI
Task X19: Development of Assays and Reagents for Zika Virus Vaccines$465,124
N01 · FY2017 · AI · contact PI
TASK X22: Non-GLP Safety Study of multivalent toxoid S. aureus Vaccine (IBT-V02) in nonhuman primates for Integrated Biotherapeutics$363,829
N01 · FY2017 · AI · contact PI
TASK X25: Preparedness for Testing NIAID Priority Vaccines in Neurovirulence and Reproductive Toxicology Studies$294,930
N01 · FY2017 · AI · contact PI
Task X21: Preparedness for Testing NIAID Priority Vaccines in General Safety and Toxicology Studies$274,639
N01 · FY2017 · AI · contact PI
TASK X23: Control Animal Meta-Analysis for Ebola and Other Filoviruses$242,829
N01 · FY2017 · AI · contact PI
Task X18: Evaluation of Filovirus Vaccines$183,769
N01 · FY2017 · AI · contact PI
Task X20: Clinical Sample Testing for Zika Virus Vaccines$80,581
N01 · FY2017 · AI · contact PI
Task X15: Evaluation of Ebolavirus and Other Filovirus Vaccines in a Novel Animal Model$45,643
N01 · FY2017 · AI · contact PI
Task X18: Evaluation of Filovirus Vaccines$4,518,280
N01 · FY2016 · AI · contact PI
Task X15: Evaluation of Ebolavirus and Other Filovirus Vaccines in a Novel Animal Model$2,492,268
N01 · FY2016 · AI · contact PI
Task X17: Malaria Vaccine Safety and Toxicology Studies$1,420,651
N01 · FY2016 · AI · contact PI
Task X19: Development of Assays and Reagents for Zika Virus Vaccines$1,233,564
N01 · FY2016 · AI · contact PI
Task X16: Yellow Fever Virus Vaccine Studies$282,536
N01 · FY2016 · AI · contact PI
Task X20: Clinical Sample Testing for Zika Virus Vaccines$198,499
N01 · FY2016 · AI · contact PI
Task X7: Preparedness for Testing Alphavirus Vaccines$129,635
N01 · FY2016 · AI · contact PI